Invriant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules
- 1 June 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (6) , 1693-1702
- https://doi.org/10.1002/eji.1830250632
Abstract
Two soluble invariant chain (Ii) peptides with overlapping sequences had contrasting effects on the presentation of antigenic peptides by murine Ad, Ak, Ed, and Ek major histocompatibility complex (MHC) class II molecules. Naturally produced class II-associated invariant chain peptides human (h)Ii81–104/murine (m)Ii80–103 inhibited antigen presentation on these MHC class II alleles in a manner consistent with competitive inhibition. The Ii-4 peptides hIi77–92/mIi76–91 enhanced presentation of antigenic peptides on I-E class II alleles by promoting the exchange of peptides at the cell surface. Treatment of antigenpresenting cells (APC) with Ii-4 before the addition of antigenic peptide greatly enhanced subsequent T cell responses, while treatment of APC with Ii–4 after antigenic peptide binding decreased subsequent T cell responses. The hIi81–104 and mIi80–103 peptides inhibited T cell responses in both types of assays. The binding of biotinylated antigenic peptide to MHC class II-transfected L cells, as measured by flow cytometry, was inhibited by mIi80-103 and enhanced by mIi-4. Segments of Ii fragments remaining associated with MHC class II, or released Ii peptides, appear to regulate the formation of stable antigenic peptide/MHC class II complexes either positively or negatively through interactions at or near the antigenic peptide binding site. These findings open a pathway for the design of novel therapeutics based on the structure and function of natural and rationally designed fragments of Ii.Keywords
This publication has 55 references indexed in Scilit:
- Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8International Immunology, 1994
- Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cellsImmunity, 1994
- Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines.The Journal of cell biology, 1994
- Diversity of Endogenous Epitopes Bound to MHC Class II Molecules Limited by Invariant ChainScience, 1994
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992
- Peptides Presented to the Immune System by the Murine Class II Major Histocompatibility Complex Molecule I-A dScience, 1992
- Intracellular transport of class II MHC molecules directed by invariant chainNature, 1990
- Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathwaysNature, 1990
- MHC class II-associated invariant chain contains a sorting signal for endosomal compartmentsCell, 1990
- Inhibition by leupeptin and antipain of the intracellular proteolysis of IiHuman Immunology, 1989